Eleftherios P Mamounas

14PUBLICATIONS
151CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 07, 2026
NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.

|Sep 11, 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.

|Jul 17, 2026
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.

|Sep 10, 2024
Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery.

Patricia A Ganz, Reena S Cecchini, Julia R White

|Jul 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Jun 04, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai

Pageof 3

Frequent Collaborators

8 joint publications

Norman Wolmark

6 joint publications

Priya Rastogi

5 joint publications

Charles E Geyer

4 joint publications

Soonmyung Paik